Genetically Modified Dendritic Cells for Cancer Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|5|6|619-628

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.6, 2005-12, pp. : 619-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Immunotherapy Using Gene-Modified Dendritic Cells

By  

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 57-78

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells: Activation and Maturation - Applications for Cancer Immunotherapy

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1783-1800

Bentham Science Publishers

Access to resources Recommend Favorite

Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells in Tumor Immunology and Immunotherapy

By  

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 17-39

Bentham Science Publishers

Access to resources Recommend Favorite

On target: Genetically modified cells show promise in targeted immunotherapy for advanced blood cancers

By Printz Carrie  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 929-930

Blackwell Publishing

Access to resources Recommend Favorite